Filing Details

Accession Number:
0001104659-19-048436
Form Type:
4
Zero Holdings:
No
Publication Time:
2019-09-03 16:04:29
Reporting Period:
2019-08-30
Accepted Time:
2019-09-03 16:04:29
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1641640 Nabriva Therapeutics Plc NBRV () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1289946 Md Colin Broom 1000 Continental Drive
Suite 600
King Of Prussia PA 19406
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Ordinary Shares Acquisiton 2019-08-30 10,177 $2.03 208,750 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Footnotes
  1. The reporting person's purchase of ordinary shares of Nabriva Therapeutics plc (the "Issuer") reported herein was matchable under Section 16(b) of the Securities Exchange Act of 1934, to the extent of 10,177 shares, with the reporting person's sale of 10,177 ordinary shares at a price of $2.07 per share on August 21, 2019. The reporting person has agreed to pay to the Issuer $397.93, representing the full amount of the profit realized in connection with the short-swing transaction.
  2. This amount represents the reporting person's total holdings of ordinary shares of the Issuer, including 72,849 ordinary shares formerly held indirectly by the reporting person in a grantor retained annuity trust. The grantor retained annuity trust has been terminated and the ordinary shares have been returned to the direct ownership of the reporting person.